Affiliation:
1. Department of Pediatrics School of Medicine West Virginia University Morgantown West Virginia USA
2. School of Medicine West Virginia University Morgantown West Virginia USA
3. Department of Biochemistry and Molecular Medicine West Virginia University Morgantown West Virginia USA
4. Department of Biostatistics School of Public Health West Virginia University Morgantown West Virginia USA
5. West Virginia Perinatal Partnership, Department of Obstetrics and Gynecology, School of Medicine West Virginia University Morgantown West Virginia USA
Abstract
AbstractPurposeTo examine the prevalence, patterns, and correlates of prenatal substance use in the rural Appalachian state of West Virginia (WV).MethodsPopulation‐based cohort (Project WATCH) of all women (N = 34,309) who gave birth between February 2020 and June 2022. A composite substance use variable included 9 categories: “no substance use,” “opioids,” “cannabis,” “sedatives/hypnotics,” “stimulants,” “opioids and cannabis,” “opioids and stimulants,” “cannabis and stimulants,” and “opioids, cannabis, and stimulants.” These data were gathered through self‐report, medical records, and/or positive drug screen at labor and delivery.Findings12.4% of women used one or more substances (opioids, cannabis, stimulants, and sedatives/hypnotics) during their current pregnancy. The mean age of women using cannabis was 25.34 (SD = 5.31), stimulants was 28.88 (SD = 5.62), and opioid was 30.19 (SD = 4.78). White women were more likely to use opioids (aOR = 2.19, 95% CI 1.46, 3.28) and less likely to use cannabis (aOR = 0.39, 95% CI 0.34, 0.44) compared to minority racial groups. Women with cannabis use were more likely to live in urban versus rural regions (aOR = 1.47, 95% CI 1.33, 1.62). The odds of using any type of substance(s) were significantly higher in women who smoked (aOR range 4.17‐30.85), had Medicaid (aOR range 1.52‐7.65), and those receiving inadequate prenatal care (aOR range 1.96‐16.83).ConclusionsIn this rural Appalachian state, 1 in 8 women used 1 or more substances (opioids, cannabis, stimulants, and/or sedatives/hypnotics) during pregnancy and the type of substance used varied by sociodemographic and health‐related factors. These factors should inform state‐level strategies and initiatives to address the substance use crisis for this population.
Subject
Public Health, Environmental and Occupational Health
Reference48 articles.
1. SAMHSA.2020 National Survey of Drug Use and Health (NSDUH) Releases.https://www.samhsa.gov/data/release/2020‐national‐survey‐drug‐use‐and‐health‐nsduh‐releasesTable 6.20B.2020. Accessed Feb 16 2023.
2. CDC.Polysubstance Use During Pregnancy. Pregnancy. Content Source.Centers for Disease Control and Prevention;2022.
3. The effects of race/ethnicity, income, and family structure on adolescent risk behaviors
4. Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999–2018
5. Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献